⌘K

Login Start Free

Home/Filings/4/0001237899-10-000014

4//SEC Filing

KOLINSKI STUART 4

Accession 0001237899-10-000014

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 6:32 PM ET

Size

26.4 KB

Accession

0001237899-10-000014

Insider Transaction Report

Form 4

Period: 2010-02-02

REGENERON PHARMACEUTICALS INCREGN

KOLINSKI STUART

SVP General Counsel and Secret

Transactions

Tax Payment
Common Stock
2010-02-02$27.16/sh−103$2,797→ 10,797 total
Tax Payment
Common Stock
2010-02-02$27.16/sh−2,734$74,255→ 16,803 total
Tax Payment
Common Stock
2010-02-02$27.16/sh−785$21,321→ 16,014 total
Sale
Common Stock
2010-02-03$27.66/sh−4,951$136,945→ 10,613 total
Exercise/Conversion
Common Stock
2010-02-02$8.50/sh+416$3,536→ 11,029 total
Tax Payment
Common Stock
2010-02-02$27.16/sh−2,174$59,046→ 14,629 total
Tax Payment
Common Stock
2010-02-02$27.16/sh−988$26,834→ 16,799 total
Sale
Common Stock
2010-02-03$28.08/sh−450$12,636→ 15,564 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-02-02−3,158→ 0 total
Exercise: $8.50Exp: 2011-01-05→ Common Stock (3,158 underlying)
Tax Payment
Common Stock
2010-02-02$27.16/sh−129$3,504→ 10,900 total
Exercise/Conversion
Common Stock
2010-02-02$8.50/sh+8,740$74,290→ 19,537 total
Exercise/Conversion
Common Stock
2010-02-02$8.50/sh+3,158$26,843→ 17,787 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-02-02−416→ 11,898 total
Exercise: $8.50Exp: 2011-01-05→ Common Stock (416 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-02-02−8,740→ 3,158 total
Exercise: $8.50Exp: 2011-01-05→ Common Stock (8,740 underlying)

Holdings

Common Stock
(indirect: By 401(k))
3,294

Footnotes (4)

[F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
[F2]The reporting person sold 4,951 shares of Company stock on February 3, 2010 at prices ranging from $27.42to $27.98. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on February 3, 2010 at each separate price.
[F3]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
[F4]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS INC

CIK 0000872589

Entity typeother

Related Parties

1

filerCIK 0001226686

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 6:32 PM ET
Size: 26.4 KB

View on SEC.gov